Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis

por Shao, Fengping, Li, Yinguang, Zhao, Yunhe
Publicado 2023

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials

por Shao, Fengping, Liu, Jun, Duan, Yaoyun, Li, Li, Liu, Liqun, Zhang, Cai, He, Shanyang
Publicado 2020

PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

por Shao, Fengping, Duan, Yaoyun, Zhao, Yunhe, Li, Yinguang, Liu, Jun, Zhang, Cai, He, Shanyang
Publicado 2021